ConductScience.org, home

Paper5963388

A new oral progestational steroid effective in treating prostatic cancer.

Scott WW and 1 other. Trans Am Assoc Genitourin Surg, 1966. Cited by 46 papers, by iCite.

Cite this record

ConductScience Library. A new oral progestational steroid effective in treating prostatic cancer. Papers, record 5963388. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5963388

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A new oral progestational steroid effective in treating prostatic cancer.
PubMed
Journal
Trans Am Assoc Genitourin Surg
PubMed
Year
1966
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
46
iCite
Revised in PubMed
2013-11-21
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Scott WWW W
2Schirmer HKH K

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ProgestinsMajor topic
Prostatic NeoplasmsMajor topic
Acid Phosphatase
Aged
Animals
Biological Assay
Castration
Dogs
Estradiol
Estrone
Humans
Liver
Liver Function Tests
Male
Prostate
Rats
Secretory Rate
Testosterone

Source PubMed

Download CSV of topics

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 46 citations.

PMIDTitleJournalYearIn PapersSource
7919640Cyproterone. A review of its pharmacology and therapeutic efficacy in prostate cancer.Drugs Aging1994https://conductscience.org/library/papers/7919640PubMed
6455833The effects of orchiectomy, oestrogens and cyproterone-acetate on the antithrombin-III concentration in carcinoma of the prostate.Urol Res1981https://conductscience.org/library/papers/6455833PubMed
6100181Gestagens in the management of prostatic carcinoma.Int Urol Nephrol1984https://conductscience.org/library/papers/6100181PubMed
5541924Progestogens and cancer.Br Med J1971https://conductscience.org/library/papers/5541924PubMed
2201397Aromatase inhibition in advanced prostatic cancer: preliminary communication.Br J Cancer1990https://conductscience.org/library/papers/2201397PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/5963388

GET https://conductscience.org/api/papers/v1/5963388/authors